Compare JNJ & LIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | LIN |
|---|---|---|
| Founded | 1886 | 1879 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 234.1B |
| IPO Year | 2003 | 2017 |
| Metric | JNJ | LIN |
|---|---|---|
| Price | $267.18 | $461.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 8 |
| Target Price | $238.20 | ★ $543.13 |
| AVG Volume (30 Days) | ★ 5.5M | 1.8M |
| Earning Date | 04-14-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.36% | 1.27% |
| EPS Growth | ★ 90.50 | 7.27 |
| EPS | 4.41 | ★ 8.13 |
| Revenue | N/A | ★ $33,986,000,000.00 |
| Revenue This Year | $6.63 | $5.90 |
| Revenue Next Year | $7.43 | $5.10 |
| P/E Ratio | $60.56 | ★ $57.40 |
| Revenue Growth | N/A | ★ 2.97 |
| 52 Week Low | $173.33 | $387.78 |
| 52 Week High | $281.07 | $548.20 |
| Indicator | JNJ | LIN |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 29.00 |
| Support Level | $263.83 | $444.02 |
| Resistance Level | $269.43 | $477.33 |
| Average True Range (ATR) | 4.60 | 6.67 |
| MACD | -0.88 | -1.54 |
| Stochastic Oscillator | 14.24 | 8.03 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.